The 12th Annual Innate Killer Summit brings together experts to discuss advancements in NK cell therapy, including preclinical and clinical developments, to address cancer, autoimmune diseases, and infectious conditions.
Key Topics
- Applications of NK biology in tackling autoimmune diseases and infectious conditions
- Developing engagers to recruit NK cells for anti-cancer activity
- Maximizing NK expansion for scalable and effective allogeneic products
- Clinical perspectives on NK therapy for autoimmune treatment
- Optimizing strategies for genetic modification of NK cells
- Leveraging combination approaches for enhanced NK therapy efficacy
- Improving resistance of NK cells to the tumor microenvironment
- Understanding the advantages of NK biology for future development
- Optimizing cryopreservation to maintain NK cell viability and efficacy
- Evaluating donor-derived versus iPSC-derived NK therapies
- Accelerating NK therapy development with clear standards and regulatory expectations
- Improving clinical NK performance for better patient outcomes
- Lengthening NK cell persistence for prolonged therapeutic benefits
Who should Attend
- Immunologists
- Researchers focused on NK cell biology
- Biotechnology professionals
- Pharmaceutical developers
- Clinical trial specialists
- Regulatory experts
- Oncologists and autoimmune disease specialists
- Therapeutics manufacturers
- Cell therapy engineers
- Academics in cellular immunotherapy
